Ligand · 4LN
4LN · N-[(2R)-10-hydroxy-2,7-dimethyl-1,2,3,4-tetrahydropyrido[1,2-b]indazol-2-yl]-4-(4H-1,2,4-triazol-4-yl)benzamide
4LN, N-[(2R)-10-hydroxy-2,7-dimethyl-1,2,3,4-tetrahydropyrido[1,2-b]indazol-2-yl]-4-(4H-1,2,4-triazol-4-yl)benzamide (C22 H22 N6 O2, 402.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site…
- Component
- 4LN
- Formula
- C22 H22 N6 O2
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
4LN in 2 structures; the first of them:
- 4Z0K · Rapid development of two Factor IXa inhibitors from Hit to Lead · 4LN A301 · binds ASN97, TYR99, HIS147, PHE174, ASP189, SER190, CYS191, GLN192 and 8 more
- 4Z0K · Rapid development of two factor ixa inhibitors from hit to lead · 4LN A301 · binds ASN97, TYR99, HIS147, PHE174, ASP189, SER190, CYS191, GLN192 and 8 more
Residues it binds most
SER 2, CYS 2, GLU 2, ASN 2, ASP 2, GLN 2, GLY 2, HIS 2, ILE 2, PHE 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.